Acute and prophylactic treatments for migraine: Present and future

Neurological Sciences

Volumn 29, Issue SUPPL. 1, 2008, Pages

  Rapoport, Alan M ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW ENGLAND CENTER FOR HEADACHE   (United States)

^c NONE   (United States)

Author keywords

Headache treatment; Migraine; Migraine acute therapy; Migraine preventive therapy

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CANDESARTAN HEXETIL; CORTICOSTEROID; ERGOT ALKALOID; FLUNARIZINE; MAGNESIUM; MELATONIN; MEMANTINE; MONOAMINE OXIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PETASITES HYBRIDUS EXTRACT; PLACEBO; PROPRANOLOL; RIBOFLAVIN; SEROTONIN AGONIST; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TANACETUM PARTHENIUM EXTRACT; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; UNINDEXED DRUG;

ADJUVANT THERAPY; AGITATION; ALOPECIA; ANALGESIC ACTIVITY; ANKLE EDEMA; ANORGASMIA; AREA UNDER THE CURVE; ARTICLE; ASTHENIA; BLURRED VISION; CLINICAL TRIAL; COGNITIVE DEFECT; COLD LIMB; CONSTIPATION; DEPRESSION; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG POTENTIATION; EMERGENCY CARE; EXERCISE TOLERANCE; FATIGUE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART DISEASE; HUMAN; HYPERACTIVITY; HYPOTENSION; INSOMNIA; LIBIDO DISORDER; MAXIMUM PLASMA CONCENTRATION; MENTAL DISEASE; MIGRAINE; MONOTHERAPY; NAUSEA; NERVOUSNESS; PAIN ASSESSMENT; PARKINSONISM; PATIENT ATTITUDE; PATIENT COUNSELING; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; TACHYCARDIA; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT PLANNING; TREMOR; UNPLEASANT DREAM; URINE RETENTION; WEIGHT GAIN; XEROSTOMIA;

HUMANS; MIGRAINE DISORDERS; PREVENTIVE MEDICINE;

EID: 45249109755     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-008-0901-x     Document Type: Article

References (36)

1. Cady RK (2001) Treatment strategies for migraine headache. JAMA 285:1014-1015
2. Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine - current understanding and treatment. N Engl J Med 346:257-270
3. Matchar DB, Young WB, Rosenberg JH et al (2000) Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. www.neurology.org. April
4. Mathew NT, Kailasam J, Fischer A (2001) Early intervention using rofecoxib alone, rizatriptan alone and combination of rizatriptan and rofecoxib in acute migraine. Cephalalgia 21:405-432
5. Hawkey CJ (1999) COX-2 inhibitors. Lancet 353:307-314
6. Krymchantowski AV, Barbosa JS (2002) Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: An open label pilot study. Cephalalgia 22:309-312
7. Klapper J, Stanton J (1991) The emergency treatment of acute migraine headache; a comparison of intravenous dihydroergota-mine, dexamethasone, and placebo. Cephalalgia 11[Suppl 11]:159-160
8. Rapoport AM, Tepper SJ (2001) Triptans are all different. Arch Neurol 58:1479-1480
9. Longmore J, Razzaque Z, Shaw D et al (1998) Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: Immunohistological demonstration of the involvement of 5-HT1B-receptors. Br J Clin Pharmacol 46:577-582
10. Kuzybski W (1992) Metamizole and hydrocortisone for the interruption of a migraine attack - preliminary study. Headache Q 3:326-328
11. Ramadan NM, Silberstein SD, Freitag FG et al (2000) Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine. www.neurology.org. April
12. Weber RB, Reinmuth OM (1971) The treatment of migraine with propranolol. Neurology 21:404-405
13. Reveiz-Herault L, Cardona AF, Ospina EG, Carrillo P (2003) [Effectiveness of flunarizine in the prophylaxis of migraine: A meta-analytical review of the literature]. Rev Neurol 36:907-912. Review, in Spanish
14. Silberstein SD (2001) Migraine: Preventive treatment. Curr Med Res Opin 17[Suppl 1]:s87-s93
15. Tomkins GE, Jackson JL, O'Malley PG et al (2001) Treatment of chronic headache with antidepressants: A meta-analysis. Am J Med 111:54-63
16. Saper JR, Silberstein SD, Lake AE et al (1995) Fluoxetine and migraine: comparison of double-blind trials. Headache 35:233
17. Mathew N, Saper J, Silberstein S et al (1995) Migraine prophylaxis with divalproex. Arch Neurol 52:281-286
18. Edwards KR, Potter DL, Wu SC et al (2003) Topiramate in the preventive treatment of episodic migraine: A combined analysis from pilot, double-blind, placebo-controlled trials. CNS Spectr 8:428-432
19. Mathew NT, Rapoport A, Saper J et al (2001) Efficacy of gabapentin in migraine prophylaxis. Headache 41:119-128
20. Steiner TJ, Findley LJ, Yuen AW (1997) Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17:109-112
21. D'Andrea G, Granella F, Cadaldini M, Manzoni GC (1999) Effectiveness of lamotrigine in the prophylaxis of migraine with aura: An open pilot study. Cephalalgia 19:64-66
22. Drake ME, Greathouse NI, Armentbright AD, Renner JB (2001) Preventive treatment of migraine with zonisamide. Cephalalgia 21:374
23. Krusz JC (2001) Levetiracetam as prophylaxis for resistant headaches. Cephalalgia 21:373
24. Sharma S, Jacobs HS (1997) Polycystic ovary syndrome associated with treatment with the anticonvulsant sodium valproate. Curr Opin Obstet Gynecol 9:391-392
25. Muller R, Weller P, Chemaissani A (1991) Pleural fibrosis as a side effect of years-long methysergide therapy. Dtsch Med Wochenschr 116:1433-1436
26. Peatfield R (1986) Drugs acting by modification os serotonin function. Headache 26:129-131
27. Haria M, Balfour JA (1997) Levetiracetam. CNS Drugs 7:159-164
28. Bigal ME, Krymchantowski AV, Rapoport AM (2003) New developments in migraine prophylaxis. Expert Opin Pharmacother 4:433-443. Review
29. Tronvik E, Stovner LJ, Helde G et al (2003) Prophylactic treatment of migraine with an angiotensin II receptor blocker: A randomized controlled trial. JAMA 289:65-69
30. Silberstein S, Mathew N, Saper J, Jenkins S (2000) Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache 40:445-450
31. Wang SJ, Fuh JL, Lu SR et al (2003) Migraine prevalence during menopausal transition. Headache 43:470-478
32. Lipton RB, Gobel H, Wilks K, Mauskop A (2002) Efficacy of petasites (an extract from petasites rhizone) 50 and 75 mg for prophylaxis of migraine: Results of a randomized, double-blind, placebo-controlled study. Neurology 58[Suppl 3]:A472
33. Altura BM, Altura BT (1978) Magnesium and vascular tone and reactivity. Blood Vessels 15:5-16
34. Welch KM, Ramadan NM (1995) Mitochondria, magnesium and migraine. J Neurol Sci 134:9-14
35. Schoenen J, Jacquy J, Lenaerts M (1998) Effectiveness of highdose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 50:466-470
36. Sandor PS, Clemente LD, Coppola G et al (2005) Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlle trial. Neurology 64:713-715